Best of BS Opinion: A jab at veracity, Jet Airways revival, and more

Here are the best of Business Standard's opinion pieces for Thursday

coronavirus, Covid-19, vaccination, vaccine
Illustration: Binay Sinha
Rajesh Kumar New Delhi
2 min read Last Updated : Jun 24 2021 | 6:30 AM IST
The euphoria over the record vaccination delivery on Monday has been tempered by sobering assessments that suggest that the numbers were achieved through some adroit inventory management by states ruled by the Bharatiya Janata Party. In this regard, our lead editorial notes that the stakeholders in the government should graduate from event management and get down to sustained work, as accelerating the pace of vaccination is becoming critical. Read here
 
Our objective should be that within three months, a dozen of our most capable pharmaceutical firms are all making vaccines by the tens of millions each month. The more the better. Tens of thousands of hospitals and clinics should each be administering hundreds and thousands of vaccines every day. Then let the market deliver, writes Naushad Forbes
 
While Jet Airways would indeed benefit from name recognition and even some loyalty from an existing customer base, the two-year gap since it shut down means that the new owners will essentially have to build the airline from the ground up, argues our second editorial

 
Quote
 
“Mobility and economic activity will likely accelerate in the second half of the year as the pace of vaccinations pick up. The government recently announced a strategy to centralise vaccine procurement in order to boost vaccinations, which if successful, will support the economic recovery.”
 
Moody's Investors Service

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :BS OpinionCurated ContentCoronavirus VaccineVaccinationJet AirwaysBharatiya Janata Partypharmaceutical firms

Next Story